Skip to main content
Livermore
Livermore
ZHEN

Van Eck Associates Corp

SEC CIK
0000869178
Latest filing
Aug 14, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of CRSP by Van Eck Associates Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−85,294−100.0%Sold outHolders
Q1 202685,294$4.06M<0.1%−537−0.6%ReducedHolders
Q4 202585,831$4.50M<0.1%+2,187+2.6%AddedHolders
Q3 202583,644$5.42M<0.1%+634+0.8%AddedHolders
Q2 202583,010$4.04M<0.1%00.0%UnchangedHolders
Q1 202583,010$2.83M<0.1%00.0%UnchangedHolders
Q4 202483,010$3.27M<0.1%+81,464+5,269.3%AddedHolders
Q3 20241,546$71.0K<0.1%−78,228−98.1%ReducedHolders
Q2 202479,774$4.31M<0.1%+7,830+10.9%AddedHolders
Q1 202471,944$4.90M<0.1%+4,103+6.0%AddedHolders
Q4 202367,841$4.25M<0.1%−4,989−6.9%ReducedHolders
Q3 202372,830$3.31M<0.1%−3,933−5.1%ReducedHolders
Q2 202376,763$4.31M<0.1%−5,863−7.1%ReducedHolders
Q1 202382,626$3.74M<0.1%−10,715−11.5%ReducedHolders
Q4 202293,341$3.79M<0.1%+14,084+17.8%AddedHolders
Q3 202279,257$5.18M<0.1%−47,002−37.2%ReducedHolders
Q2 2022126,259$7.67M<0.1%+12,198+10.7%AddedHolders
Q1 2022114,061$7.16M<0.1%+10,015+9.6%AddedHolders
Q4 2021104,046$7.88M<0.1%+7,694+8.0%AddedHolders
Q3 202196,352$10.8M<0.1%−7,807−7.5%ReducedHolders
Q2 2021104,159$16.9M<0.1%−14,922−12.5%ReducedHolders
Q1 2021119,081$14.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.